CLINICAL_TRIALS
trial_result
· 2015-11-03
Clinical Trial Update: Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis [Phase 3]
Summary
A Phase 3 trial evaluating AIN457 (secukinumab) for active non-infectious uveitis was terminated, with safety and efficacy results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Uveitis | Phase 3 | Status: TERMINATED | Results posted: 2015-11-03